The Pharmally Pharmaceutical Corporation official who earlier admitted to tampering the manufacturing dates of face shields they delivered to the government failed to appear in the continuation of the Senate Blue Ribbon Committee’s investigation into the alleged overpriced COVID-19 pandemic supplies